Antiviral activity of compounds modified from the imidazolidinone derivative Impacarzinum.
D000818:Animals; D000998:Antiviral Agents; D004267:DNA Viruses / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004352:Drug Resistance, Microbial; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000188:drug therapy; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D012328:RNA Viruses / Q000187:drug effects; D011817:Rabbits; D014777:Virus Diseases / Q000188:drug therapy*
D000998:Antiviral Agents; D007093:Imidazoles; D010879:Piperazines; C011009:impacarzinum